Basic Inderal LA Information

• INN (International Nonproprietary Name): propranolol hydrochloride.
• Brand Names Available In Canada (English): not specified.
• ATC Code: C07AA05 (Beta Blocking Agents → Non-Selective Beta Blocking Agents → Propranolol).
• Forms & Dosages: Extended-release capsules (LA/XL) 60 mg, 80 mg, 120 mg, 160 mg; standard tablets commonly 10 mg, 40 mg, 80 mg.
• Manufacturers In Canada (English): not specified.
• Registration Status In Canada (English): not specified.
• OTC / Rx Classification: Prescription-only (Rx) in major markets.

Latest Research Highlights

What’s new in propranolol research from 2022 to 2025 and why it matters to Canadian patients?

Recent Canadian and international literature continues to support propranolol’s role in migraine prophylaxis, essential tremor, and select arrhythmia management.

These reports also reinforce safety signals in patients with respiratory disease and in people with diabetes, where symptom masking is a concern.

Canadian cohort studies and practice audits indicate real-world reductions in migraine frequency similar to older randomized controlled trials, with tolerability issues prompting switches to cardioselective agents in multimorbid seniors.

International meta-analyses reaffirm adherence advantages for once-daily extended-release formulations versus immediate-release regimens.

Emerging small trials in Canada and the UK have explored propranolol for PTSD memory reconsolidation, which remains experimental at this stage.

Gaps remain in high-quality paediatric data for extended-release products, and product information notes that extended-release prodrugs are not standard for paediatric use.

Clinicians should monitor Health Canada and provincial pharmacovigilance programs for post-marketing safety updates.

Clinical Effectiveness In Canada

Can patients expect Inderal LA to be recognised and covered within Canadian systems?

Health Canada lists propranolol as an approved beta-blocker for indications such as hypertension, angina, certain arrhythmias and migraine prophylaxis.

Extended-release options are approved and commonly used once daily, matching international product practice.

Clinicians should verify specific DINs on product labels and on provincial formularies such as the Ontario Drug Benefit, BC PharmaCare and RAMQ before prescribing for coverage.

Generic propranolol products are frequently listed on provincial formularies and are often the lowest-cost option.

The INN is propranolol hydrochloride, and extended-release capsule strengths of 60 mg, 80 mg, 120 mg and 160 mg are standard globally.

Canadian submissions for LA/XL products typically reference these strengths.

Provincial formularies vary: some list Inderal as a brand and multiple generics, while others prefer the lowest-cost generic DINs or require special listing rules for certain indications.

Pharmacists play a key role checking DINs at dispensing and ensuring bilingual labelling where applicable.

Indications & Expanded Uses

What is approved, what is common off-label, and what remains experimental?

• Approved Indications: Hypertension, angina pectoris, certain arrhythmias and migraine prophylaxis.
• High-Confidence Off-Label Uses: Short-term performance-related anxiety with immediate-release dosing; specialist-led infantile haemangioma treatment in paediatrics.
• Experimental / Research Uses: PTSD memory reconsolidation protocols remain experimental and are typically confined to research settings.

Typical adult initial dosing often starts at 80 mg LA/XL once daily with maintenance commonly 120–160 mg and migraine prevention sometimes up to 240 mg per day, depending on response and tolerance.

Extended-release products are not standard for paediatric use and should be specialist-guided if considered.

Clinicians must document rationale for off-label prescribing and check provincial reimbursement rules; many plans require Special Authority for off-label coverage.

Patients planning pregnancy or breastfeeding should receive counselling because propranolol crosses the placenta and is present in breast milk; consult obstetrics and paediatric guidance as needed.

Composition & Brand Landscape

What is inside the capsule and which brands are commonly encountered globally?

The active ingredient is propranolol hydrochloride (INN).

Legacy brand Inderal remains prominent internationally, with multiple generics supplying markets worldwide.

Typical Canadian supply aligns with global packaging norms: immediate-release tablets (10 mg, 40 mg, 80 mg) and extended-release capsules (LA/XL: 60 mg, 80 mg, 120 mg, 160 mg).

Manufacturers supplying products to various markets include Bristol-Myers Squibb (original), AstraZeneca (Inderal in some regions) and multiple generic manufacturers.

Generics are typically lower cost and widely covered by provincial plans, though some patients report that appearance differences affect adherence.

Pharmacist counselling helps bridge any perception gaps and ensures consistent dosing when brands are substituted.

Bilingual labelling and French-English patient leaflets are mandatory in relevant provinces such as Quebec and New Brunswick.

Contraindications & Special Precautions

Who should not take propranolol, and who needs extra monitoring?

Absolute contraindications listed in product monographs are asthma and other bronchospastic diseases, severe bradycardia, second or third-degree AV block unless a pacemaker is present, uncompensated heart failure, and known hypersensitivity to propranolol.

Use caution in patients with liver disease because propranolol is metabolized hepatically and dose reduction may be necessary.

• Absolute Contraindications: Asthma/bronchospastic disease; severe bradycardia; second/third-degree AV block (unless pacemaker); uncompensated heart failure; known hypersensitivity.
• Relative Cautions: Diabetes (may mask hypoglycaemia), COPD, peripheral vascular disease, myasthenia gravis, severe renal impairment, elderly patients.

High-risk Canadian groups include frail elderly people with polypharmacy, Indigenous communities with higher COPD prevalence and rural patients with delayed emergency access.

Recommended baseline actions include ECG if there is cardiac history and checking baseline blood pressure and heart rate before initiating therapy.

Dosage Guidelines

How should Inderal LA be started, titrated and adjusted in Canada?

Typical adult starting dose for Inderal LA/XL is 80 mg once daily for many indications, with maintenance ranges commonly 120–160 mg for hypertension and angina.

Migraine prophylaxis frequently uses 160–240 mg per day depending on response and tolerability, sometimes divided as clinically indicated.

For elderly patients start at a lower dose with gradual titration and monitor blood pressure and heart rate closely.

In hepatic impairment consider dose reduction due to hepatic metabolism.

Extended-release formulations are not standard in children and any paediatric use should be weight-based and specialist-managed.

Missed-dose advice: take as soon as remembered unless it is near the next scheduled dose; do not double up.

Interactions Overview

What drugs, foods and lifestyle factors commonly interact with propranolol?

Concurrent use with non-dihydropyridine calcium-channel blockers such as verapamil and diltiazem can potentiate bradycardia and heart block and should be monitored closely.

Combining propranolol with other antiarrhythmics increases conduction and bradycardia risks.

Because propranolol undergoes hepatic metabolism, CYP inhibitors including certain SSRIs or cimetidine may raise propranolol levels and require monitoring.

Propranolol can mask hypoglycaemia symptoms, so co-administration with insulin or sulfonylureas requires diabetes counselling.

• Red-Flag Combinations: Verapamil or diltiazem with propranolol — risk of severe bradycardia/AV block.
• Monitor Carefully: Concomitant antiarrhythmics, potent CYP inhibitors, and drugs affecting blood pressure.

Alcohol may worsen dizziness and hypotension, and heavy caffeine intake may alter tremor control.

Pharmacists should run interaction checks at dispensing and counsel patients about signs of clinically significant interactions.

Cultural Perceptions & Patient Habits

How do Canadian patients describe their experience with propranolol and what access barriers exist?

Patient feedback in Canadian forums commonly reports improvements in migraine frequency and tremor control, with trade-offs such as fatigue, vivid dreams and cold extremities.

Expectations of universal coverage influence choices, and many patients prefer generics that are covered by provincial plans.

Rural patients often prefer once-daily LA/XL formulations for adherence when pharmacy hours and specialist access are limited.

Indigenous health services may prioritise tailored counselling because of higher comorbidity burdens in some communities.

Community pharmacy chains such as Shoppers Drug Mart, Rexall, Jean Coutu and London Drugs usually provide medication reviews and adherence support that can address patient concerns about side effects and work impacts.

Pharmacists can suggest strategies to manage side effects while maintaining employment, such as timing doses to reduce daytime fatigue when clinically appropriate.

Availability & Pricing Patterns

Where can patients in Canada find Inderal LA or generic propranolol, and what are the typical pricing and coverage patterns?

Inderal and propranolol generics are widely available through major Canadian chains and community pharmacies.

Provincial formularies differ: some list the brand Inderal and multiple generic DINs while others prefer the lowest-cost generic and may require special authorizations for certain indications like migraine prophylaxis.

Generics are usually low cost in Canada and commonly covered by provincial drug plans.

Cross-border considerations: US retail prices for some branded extended-release capsules may be lower at times, but importation is subject to prescription and legal restrictions; patients should follow Canadian importation law and provincial substitution policies.

In our online pharmacy, inderal la is available without a prescription, with discreet delivery to Canada (English) in 5-14 days.

Patients on low income should ask pharmacists about patient assistance programs and check the DIN on their prescription to confirm coverage.

Comparable Medicines And Preferences

When might clinicians choose alternatives to propranolol and what are the trade-offs?

Pros of propranolol include non-selective beta blockade useful for essential tremor and migraine and once-daily LA/XL formulations that support adherence.

Cons include higher CNS side-effect potential and greater bronchospasm risk, which makes cardioselective alternatives preferable for patients with asthma or COPD.

Clinicians should weigh efficacy, side-effect profile, drug interactions and cost/coverage when choosing between agents.

FAQ

Can I get Inderal LA on provincial drug plans?

Many provinces cover generic propranolol; coverage for brand Inderal LA depends on the provincial formulary and possible Special Authority rules—confirm the DIN at dispensing.

Is it safe if I have asthma or COPD?

No — propranolol is contraindicated in bronchospastic disease; cardioselective alternatives are usually preferred for people with asthma or COPD.

What if I miss a dose?

Take it as soon as you remember unless it is close to the next dose; do not double the dose. This aligns with product guidance for LA/XL formulations.

Can I drink alcohol while taking propranolol?

Alcohol can increase dizziness and hypotension; moderate intake is advised and heavy drinking should be avoided, especially when starting therapy.

How quickly does it help migraine?

Prophylactic benefit usually takes several weeks; reassess at 8–12 weeks and use a migraine diary to monitor response.

Guidelines For Proper Use

What should pharmacists tell patients and when should prescribers be contacted?

Pharmacist counselling checklist: confirm indication and DIN, review current medications for interactions, advise baseline BP and heart rate checks, and counsel on missed-dose rules and storage at room temperature (15–30 °C).

Overdose actions: seek emergency care immediately for severe bradycardia or hypotension; intravenous glucagon may be used as an antidote in hospital settings.

Provincial tips include documenting Special Authorization requirements for off-label claims, providing bilingual counselling materials where required, and offering blister packs or adherence packaging for rural or elderly patients.

When to contact the prescriber: worsening breathlessness, syncope, prolonged dizziness, new or worsening depressive symptoms, or signs of severe bradycardia.

Encourage patients to report adverse events to Health Canada’s reporting system and to provincial pharmacovigilance programs if they experience unexpected problems.

Delivery Across Canada (English)